m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis

被引:12
|
作者
Jiang, Xiaohan [1 ]
Jin, Ziyao [2 ]
Yang, Yuzhong [1 ]
Zheng, Xiang [1 ]
Chen, Shaohua [3 ]
Wang, Shuaijie [1 ]
Zhang, Xuemei [4 ]
Qu, Nanfang [5 ]
机构
[1] Guilin Med Univ, Affiliated Hosp, Dept Pathol, Guilin, Peoples R China
[2] Zhejiang Univ, Stomatol Hosp, Sch Stomatol, Key Lab Oral Biomed Res Zhejiang Prov,Sch Med, Hangzhou, Peoples R China
[3] Guangxi Med Univ, Liuzhou Peoples Hosp, Dept Breast & Thyroid Surg, Liuzhou, Peoples R China
[4] Guangxi Med Univ, Liuzhou Peoples Hosp, Dept Pathol, Liuzhou, Peoples R China
[5] Guilin Med Univ, Affiliated Hosp, Dept Gastroenterol, Guilin, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
colorectal cancer; N6-methyladenosine; RNA modification; proliferation; tumorigenesis; MESSENGER-RNA METHYLATION; PENTOSE-PHOSPHATE PATHWAY; N6-METHYLADENOSINE MODIFICATION; AEROBIC GLYCOLYSIS; M(6)A MODIFICATION; GENE-EXPRESSION; NUCLEAR-RNA; PROGRESSION; PROMOTES; DEMETHYLASE;
D O I
10.3389/fonc.2023.1162300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
N6-methyladenosine (m6A) is the most pervasive RNA modification in eukaryotic cells. The dynamic and reversible m6A modification of RNA plays a critical role in the occurrence and progression of tumors by regulating RNA metabolism, including translocation, mRNA stability or decay, pre-mRNA splicing, and lncRNA processing. Numerous studies have shown that m6A modification is involved in the development of various cancers. This review aims to summarize the significant role of m6A modification in the proliferation and tumorigenesis of CRC, as well as the potential of modulating m6A modification for tumor treatment. These findings may offer new therapeutic strategies for clinical implementation of m6A modification in CRC in the near future.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction
    Li, Jian
    Wang, Fangjuan
    Liu, Yongkang
    Wang, Huaizhi
    Ni, Bing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (09): : 2323 - 2335
  • [22] The Role of m6A Modification and m6A Regulators in Esophageal Cancer
    Li, Yuekao
    Niu, Chaoxu
    Wang, Na
    Huang, Xi
    Cao, Shiru
    Cui, Saijin
    Chen, Tianyu
    Huo, Xiangran
    Zhou, Rongmiao
    CANCERS, 2022, 14 (20)
  • [23] SHMT2 promotes the tumorigenesis of renal cell carcinoma by regulating the m6A modification of PPAT
    Huo, Fu-Chun
    Xie, Min
    Zhu, Zhi-Man
    Zheng, Jun-Nian
    Pei, Dong-Sheng
    GENOMICS, 2022, 114 (04)
  • [24] The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer
    Xu, Xinwei
    Huang, Jintu
    Ocansey, Dickson Kofi Wiredu
    Xia, Yuxuan
    Zhao, Zihan
    Xu, Zhiwei
    Yan, Yongmin
    Zhang, Xu
    Mao, Fei
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 3289 - 3306
  • [25] m6A modification: a new avenue for anti-cancer therapy
    Bai, Yongtai
    Li, Kai
    Peng, Jinying
    Yi, Chengqi
    LIFE MEDICINE, 2023, 2 (01):
  • [26] Targeting the RNA m6A modification for cancer immunotherapy
    Li, Xinxin
    Ma, Shoubao
    Deng, Youcai
    Yi, Ping
    Yu, Jianhua
    MOLECULAR CANCER, 2022, 21 (01)
  • [27] Crosstalk between m6A modification and autophagy in cancer
    Chen, Tao
    Zheng, Liying
    Luo, Peiyue
    Zou, Jun
    Li, Wei
    Chen, Qi
    Zou, Junrong
    Qian, Biao
    CELL AND BIOSCIENCE, 2024, 14 (01)
  • [28] The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
    Mao, Zhonghao
    Wang, Bingyu
    Zhang, Teng
    Cui, Baoxia
    CELL DEATH & DISEASE, 2023, 14 (11)
  • [29] The emerging importance role of m6A modification in liver disease
    Wang, Sheng
    Gao, Songsen
    Ye, Wufei
    Li, Yueran
    Luan, Jiajie
    Lv, Xiongwen
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [30] The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer
    Qiao, Haiyan
    Liu, Linfeng
    Chen, Jun
    Shang, Bingbing
    Wang, Liang
    MEDICAL ONCOLOGY, 2022, 39 (12)